Company Data
Aptevo Therapeutics Inc.
Ticker
APVO
Current Price
$3.34 -8.24%
Market Cap
$1.7M
Price Target
Refer to Report
Volume
134.3K
52wk Range
$3.52 - $399.6
Overview
Aptevo Therapeutics Inc is a biosciences company. The company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics. Its pipeline product includes Otlertuzumab, APVO414, ROR1 Candidate, Multiple ADAPTIR Candidates, ALG.APV-527, APVO436 and APVO210.